Eli Lilly said Monday that some Medicare beneficiaries could pay more than the widely cited $50 monthly cap for weight‑loss drugs under a new federal coverage model, cautioning that cost‑sharing may vary across a limited number of basic Medicare Part D plans. The company said in a press release that most participating plans are expected to honor the $50 out‑of‑pocket limit, but a small subset may not fully comply with the cap. The issue stems from a voluntary program launched by the Centers for